Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cataplexy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01800045
What this trial is testing

Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)

Who this might be right for
Narcolepsy With CataplexyExcessive Daytime Sleepiness
Bioprojet 103
Not applicableStudy completedNCT05375890
What this trial is testing

Clinical and Neurophysiological Characteristics of Narcolepsy

Who this might be right for
Narcolepsy Type 1
I.M. Sechenov First Moscow State Medical University 89
Not applicableStudy completedNCT05709873
What this trial is testing

Narcolepsy Nightmare Study

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+2 more
Northwestern University 7
Large-scale testing (Phase 3)Looking for participantsNCT07540364
What this trial is testing

Evaluate the Efficacy and Safety of Samelisant in Patients With Narcolepsy (AWAKE)

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 240
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Large-scale testing (Phase 3)Study completedNCT04451668
What this trial is testing

An Open Label Study of FT218 in Subjects With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Somnolence+3 more
Avadel 184
Large-scale testing (Phase 3)Study completedNCT06505031
What this trial is testing

TAK-861 in People With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 105
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT05687916
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Takeda 71
Large-scale testing (Phase 3)Looking for participantsNCT07675135
What this trial is testing

Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

Who this might be right for
EDSCataplexyFatigue+1 more
Harmony Biosciences Management, Inc. 258
Large-scale testing (Phase 3)Study completedNCT03030599
What this trial is testing

The Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 201
Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Large-scale testing (Phase 3)Study completedNCT01067222
What this trial is testing

Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy+1 more
Bioprojet 110
Testing effectiveness (Phase 2)Study completedNCT04923594
What this trial is testing

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy Narcolepsy
NLS Pharmaceutics 67
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT06952699
What this trial is testing

TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Who this might be right for
Narcolepsy Type 2
Takeda 88
Large-scale testing (Phase 3)Study completedNCT02720744
What this trial is testing

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

Who this might be right for
Excessive Daytime SleepinessCataplexyNarcolepsy
Avadel 212
Testing effectiveness (Phase 2)Study completedNCT01183312
What this trial is testing

Flumazenil for the Treatment of Primary Hypersomnia

Who this might be right for
HypersomniaPrimary HypersomniaIdiopathic Hypersomnia+1 more
Lynn Marie Trotti 10
Testing effectiveness (Phase 2)Study completedNCT01146600
What this trial is testing

Clarithromycin for the Treatment of Hypersomnia

Who this might be right for
HypersomniaIdiopathic HypersomniaNarcolepsy
Lynn Marie Trotti 26
Not applicableStudy completedNCT04306952
What this trial is testing

Awareness and Self-Compassion Enhancing Narcolepsy Treatment

Who this might be right for
NarcolepsyNarcolepsy Without CataplexyNarcolepsy With Cataplexy
Northwestern University 60
Next Page